Principal Investigators
Dr Bradley Turner
Institution
University of Melbourne
Contact information of lead PI
Country
Australia
Title of project or programme
SMN immunogene therapy for motor neuron disorders
Source of funding information
National Health and Medical Research Council
Total sum awarded (Euro)
402,170
Start date of award
01/01/2016
Total duration of award in years
3
Keywords
Research Abstract
We have designed novel gene therapy agents to treat MND. This therapeutic approach uniquely combines gene therapy agents with antibodies which stimulate motor neuron health and connections to muscle. This project will comprehensively characterise the therapeutic effects of our novel gene therapy agents in MND mice. We predict that our gene therapy complexes will improve motor neuron survival,motor function and lifespan in MND mice.
Further information available at:
Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A